US Stocks That May Be Priced Below Intrinsic Value Estimates In October 2024
In This Article:
As of October 2024, the U.S. stock market is experiencing mixed performances amid a wave of earnings reports, with the Nasdaq Composite rising for its fifth consecutive session while the Dow Jones Industrial Average and S&P 500 see slight declines. In this environment, identifying stocks that may be priced below their intrinsic value can offer potential opportunities for investors seeking to navigate these fluctuating market conditions effectively.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Western Alliance Bancorporation (NYSE:WAL) | $82.34 | $162.91 | 49.5% |
| MidWestOne Financial Group (NasdaqGS:MOFG) | $29.11 | $57.14 | 49.1% |
| Associated Banc-Corp (NYSE:ASB) | $22.42 | $43.47 | 48.4% |
| Atlanticus Holdings (NasdaqGS:ATLC) | $36.92 | $72.49 | 49.1% |
| EQT (NYSE:EQT) | $35.97 | $69.67 | 48.4% |
| UFP Technologies (NasdaqCM:UFPT) | $276.41 | $537.49 | 48.6% |
| Vitesse Energy (NYSE:VTS) | $24.91 | $49.16 | 49.3% |
| Fiverr International (NYSE:FVRR) | $21.53 | $42.25 | 49% |
| Bowhead Specialty Holdings (NYSE:BOW) | $29.15 | $57.38 | 49.2% |
| Reddit (NYSE:RDDT) | $77.29 | $153.96 | 49.8% |
Let's take a closer look at a couple of our picks from the screened companies.
CrowdStrike Holdings
Overview: CrowdStrike Holdings, Inc. offers cybersecurity solutions globally and has a market cap of approximately $75.88 billion.
Operations: CrowdStrike Holdings generates revenue primarily from its Security Software & Services segment, amounting to $3.52 billion.
Estimated Discount To Fair Value: 26.6%
CrowdStrike Holdings is trading below its estimated fair value, presenting potential undervaluation based on cash flows. Despite recent legal challenges and insider selling, the company's earnings are forecasted to grow significantly faster than the US market. Recent strategic partnerships and innovations in cybersecurity enhance its competitive position. However, shareholder dilution over the past year could be a concern for investors evaluating long-term value creation.
DexCom
Overview: DexCom, Inc. is a medical device company that specializes in the design, development, and commercialization of continuous glucose monitoring systems both in the United States and internationally, with a market cap of approximately $29.10 billion.
Operations: The company generates revenue primarily from its patient monitoring equipment segment, amounting to $3.93 billion.